03017nas a2200433 4500000000100000008004100001260001300042653001500055653001000070653002100080653001000101653002100111653003300132653002000165653002500185653002100210653001100231653001100242653001200253653000900265653001600274653001500290653002000305653003000325653002100355653001800376653003000394100001300424700001200437700001200449700001800461245012100479856005100600300001100651490000700662050001400669520188600683022001402569 2004 d c2004 Dec10aAdolescent10aAdult10aAge Distribution10aChild10aChild, Preschool10aCommunicable Disease Control10aContact Tracing10aDeveloping countries10aEndemic Diseases10aFemale10aHumans10aleprosy10aMale10aMiddle Aged10aPrevalence10aRisk Assessment10aSeverity of Illness Index10aSex Distribution10aSurvival Rate10aWorld Health Organization1 aMoet F J1 aMeima A1 aOskam L1 aRichardus J H00aRisk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions. uhttps://leprosyreview.org/article/75/4/31-0326 a310-260 v75 aMOET 20043 a

Existing knowledge on risk factors for the development of clinical leprosy among contacts of known leprosy patients is reviewed with the aim to identify factors associated with leprosy among contacts that have potential for developing effective targeted interventions in leprosy control. Different definitions of 'contact' have been used and most studies on this subject were among so-called household members. Yet several studies indicate that contacts found in other places than the household are also at risk of developing leprosy. The type of leprosy and the bacterial index are the main patient-related factors involved in transmission, but also contacts of PB patients have a higher risk of contracting leprosy as compared to the general population. The most important contact-related factors are the closeness and intensity of the contact and inherited susceptibility, while the role of age and sex of the contacts is not clear. The role of socio-economic factors is also vague. The significance of immunological and molecular markers in relation to risk of transmitting or developing leprosy is not yet fully understood, but there is an indication that contacts who are sero-positive for anti-PGL-I antibodies are at increased risk of developing clinical leprosy. The presence of a BCG scar is likely to be related to a lower risk. Analogies with tuberculosis suggest that the 'stone-in-the-pond' approach to control may be applicable to leprosy too. Sputum smear negative tuberculosis patients are known to spread the bacteria to others. This analogy strengthens the suggestion that the contacts of paucibacillary leprosy cases should also be included in contact tracing and examination. It is concluded that targeted interventions should be aimed at close contacts of both MB and PB patients inside and outside the household, particularly when genetically related.

 a0305-7518